Skip to content

Clinical application of Eph: a randomized controlled trial

Clinical application of Eph: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037960
Enrollment
Unknown
Registered
2020-09-07
Start date
2016-09-01
Completion date
Unknown
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Interventions

experimental group:RPH

Sponsors

Shanghai Yangpu District Shidong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patient meet the surgical indication: in accordance with "the surgery of Chinese medical association branch of colorectal surgery group standards set by the" III, IV period of prolapse of hemorrhoids, hemorrhoids ring mixed hemorrhoids, incarcerated hemorrhoids (should be again after inflammation subsidise the surgery), rectal mucosa prolapse; 2. Patients between 18 and 60 years old men or women. Informed consent and relevant notification have been completed.

Exclusion criteria

Exclusion criteria: Patients with anal fistula, perianal abscess, anal fissure, digestive tract infectious diseases, mental illness, diabetes, severe cardiovascular and cerebrovascular diseases, severe allergies, clotting dysfunction, pregnant women, menstrual period, specific infections (such as tuberculosis, Crohn's disease, ulcerative colitis, etc.) or malignant tumors.

Design outcomes

Primary

MeasureTime frame
bleeding;The pain;rectostenosis;Surgery time;Rectal mucosal stricture;

Countries

China

Contacts

Public ContactShaoming Chen

Shanghai Yangpu District Shidong Hospital

395276816@qq.com+86 13564644488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026